×
About 3,669 results

ALLMedicine Bacterial Pneumonia Center

Research & Reviews  1,513 results

Diagnostic accuracy of procalcitonin for bacterial pneumonia in children - a systematic...
https://doi.org/10.1080/23744235.2020.1788719
Infectious Diseases (London, England); Tsou PY, Rafael J et. al.

Jul 2nd, 2020 - Objective: The predictive role of procalcitonin for childhood bacterial pneumonia, a leading cause of death, is unclear. We aimed to evaluate the diagnostic accuracy of procalcitonin for childhood bacterial pneumonia.Methods: Major bibliographic d...

Post-mortem histopathology of a pediatric brain after bilateral DBS of GPI for status d...
https://doi.org/10.1007/s00381-020-04761-w
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery; Giordano F, Caporalini C et. al.

Jul 1st, 2020 - To investigate the effects of deep brain stimulation (DBS) electrodes on the brain of a dystonic pediatric patient submitted to bilateral DBS of the globus pallidus internus (GPI). An 8-year-old male patient underwent bilateral DBS of GPI for stat...

Fatal outcome in a patient under immunosuppressant therapy infected with human T-lympho...
https://doi.org/10.1186/s12879-020-05195-0
BMC Infectious Diseases; Ashida C, Kinoshita K et. al.

Jul 1st, 2020 - Strongyloidiasis is a gastrointestinal parasitic infection caused by percutaneous infection with Strongyloides stercoralis. Digestive symptoms such as diarrhea and abdominal pain are the main manifestation, but serious infections such as septicemi...

Understanding Early and Late Endpoints in Registrational Trials of Community-acquired B...
https://doi.org/10.1093/cid/ciaa853
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Talbot GH

Jun 25th, 2020 - Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia.|2020|Talbot GH,|

Concordance of early and late endpoints for community-acquired bacterial pneumonia trials.
https://doi.org/10.1093/cid/ciaa860
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Bart SM, Nambiar S et. al.

Jun 25th, 2020 - While there are ongoing regulatory convergence efforts, differences remain in primary endpoints recommended for community-acquired bacterial pneumonia (CABP) trials. The US Food and Drug Administration recommends assessing CABP symptom resolution ...

see more →

Guidelines  7 results

Shared Decision-Making for Administering PCV13 in Older Adults
https://www.aafp.org/afp/2020/0201/p134.html
American Family Physician; Shah AA,et al

Jan 31st, 2020 - Streptococcus pneumoniae infection, the most common cause of bacterial pneumonia, leads to significant morbidity and mortality in older people. With the addition of the pneumococcal conjugate vaccine to childhood immunization schedules in 2000, he...

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-announces-us-fda-approval-supplemental-new

Oct 23rd, 2019 - Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced the U.S. Food and Drug Administration (FDA) has appr...

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to...
https://doi.org/10.1093/cid/ciw258
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Knirsch C, Alemayehu D et. al.

Aug 2nd, 2016 - The etiology of hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) is often multidrug-resistant infections. The evaluation of new antibacterial drugs for efficacy in this population is important, as many antibacterial drugs...

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventil...
https://doi.org/10.1093/cid/ciw316
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Donnelly H, Alemayehu D et. al.

Aug 2nd, 2016 - Resistant bacteria are one of the leading causes of hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP). HABP/VABP trials are complex and difficult to conduct due to the large number of medical procedures, adverse events, and c...

XENLETA™ (lefamulin) Website for Healthcare Professionals
https://www.xenleta.com/

community-acquired bacterial pneumonia See XENLETA™ (lefamulin) clinical trial results and product attributes

see more →

Drugs  133 results see all →

Clinicaltrials.gov  1,797 results

Diagnostic accuracy of procalcitonin for bacterial pneumonia in children - a systematic...
https://doi.org/10.1080/23744235.2020.1788719
Infectious Diseases (London, England); Tsou PY, Rafael J et. al.

Jul 2nd, 2020 - Objective: The predictive role of procalcitonin for childhood bacterial pneumonia, a leading cause of death, is unclear. We aimed to evaluate the diagnostic accuracy of procalcitonin for childhood bacterial pneumonia.Methods: Major bibliographic d...

Post-mortem histopathology of a pediatric brain after bilateral DBS of GPI for status d...
https://doi.org/10.1007/s00381-020-04761-w
Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery; Giordano F, Caporalini C et. al.

Jul 1st, 2020 - To investigate the effects of deep brain stimulation (DBS) electrodes on the brain of a dystonic pediatric patient submitted to bilateral DBS of the globus pallidus internus (GPI). An 8-year-old male patient underwent bilateral DBS of GPI for stat...

Fatal outcome in a patient under immunosuppressant therapy infected with human T-lympho...
https://doi.org/10.1186/s12879-020-05195-0
BMC Infectious Diseases; Ashida C, Kinoshita K et. al.

Jul 1st, 2020 - Strongyloidiasis is a gastrointestinal parasitic infection caused by percutaneous infection with Strongyloides stercoralis. Digestive symptoms such as diarrhea and abdominal pain are the main manifestation, but serious infections such as septicemi...

Tygacil - tigecycline injection, powder, lyophilized, for solution-Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465

Jun 29th, 2020 - TYGACIL is a tetracycline class antibacterial indicated in patients 18 years of age and older for: Complicated skin and skin structure infections (1.1) Complicated intra-abdominal infections (1.2) Community-acquired bacterial pneumonia (1.3) Limit...

Understanding Early and Late Endpoints in Registrational Trials of Community-acquired B...
https://doi.org/10.1093/cid/ciaa853
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Talbot GH

Jun 25th, 2020 - Understanding Early and Late Endpoints in Registrational Trials of Community-acquired Bacterial Pneumonia.|2020|Talbot GH,|

see more →

News  217 results

Fast Five Quiz: Pneumonia Key Aspects
https://www.medscape.com/viewarticle/922410

Mar 22nd, 2020 - Bacterial pneumonia is caused by a pathogenic infection of the lungs and may present as a primary disease process or as the final, fatal disorder, primarily in an individual who is already debilitated. Community-acquired pneumonia (CAP) is one of ...

Shared Decision-Making for Administering PCV13 in Older Adults
https://www.aafp.org/afp/2020/0201/p134.html
American Family Physician; Shah AA,et al

Jan 31st, 2020 - Streptococcus pneumoniae infection, the most common cause of bacterial pneumonia, leads to significant morbidity and mortality in older people. With the addition of the pneumococcal conjugate vaccine to childhood immunization schedules in 2000, he...

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-announces-us-fda-approval-supplemental-new

Oct 23rd, 2019 - Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced the U.S. Food and Drug Administration (FDA) has appr...

Lefamulin found noninferior to moxifloxacin for bacterial pneumonia
https://www.mdedge.com/pulmonary-health-hub/article/209198/infectious-diseases/lefamulin-found-noninferior-moxifloxacin?channel=94
Heidi Splete

Oct 1st, 2019 - Persistent high rates of bacterial resistance to current treatments have created the need for more options, especially for the treatment of community-acquired bacterial pneumonia (CABP), which remains a leading cause of hospitalization and death i.

Years ago, this doctor linked a mysterious lung disease to vaping
https://www.mdedge.com/pediatrics/article/206955/pulmonology/years-ago-doctor-linked-mysterious-lung-disease-vaping/page/0/1?channel=27980

Aug 23rd, 2019 - We really felt that it wasn’t going to be a one-off event and that it was what we usually called in public health a “sentinel” health event … that it was an example of a respiratory illness that can be caused by this exposure and that it probably.

see more →

Patient Education  2 results see all →